1. Home
  2. CDNA vs VSAT Comparison

CDNA vs VSAT Comparison

Compare CDNA & VSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$54.33

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo ViaSat Inc.

VSAT

ViaSat Inc.

HOLD

Current Price

$76.38

Market Cap

9.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
VSAT
Founded
1998
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
9.6B
IPO Year
2007
1996

Fundamental Metrics

Financial Performance
Metric
CDNA
VSAT
Price
$54.33
$76.38
Analyst Decision
Buy
Strong Buy
Analyst Count
6
6
Target Price
$28.00
$59.80
AVG Volume (30 Days)
1.0M
1.4M
Earning Date
04-28-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
94.42
EPS
2.13
N/A
Revenue
$48,324,000.00
N/A
Revenue This Year
$16.01
$5.32
Revenue Next Year
$11.31
$3.57
P/E Ratio
$25.21
N/A
Revenue Growth
18.93
N/A
52 Week Low
$13.95
$26.10
52 Week High
$55.16
$93.03

Technical Indicators

Market Signals
Indicator
CDNA
VSAT
Relative Strength Index (RSI) 68.92 55.39
Support Level $45.74 $66.99
Resistance Level N/A $79.83
Average True Range (ATR) 2.02 3.92
MACD -0.03 0.54
Stochastic Oscillator 81.33 78.97

Price Performance

Historical Comparison
CDNA
VSAT

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About VSAT ViaSat Inc.

Viasat Inc an world-wide provider of communications technologies and services, focused on making connectivity accessible, available and secure for current and future customers world-wide. The company has two reportable segments: communication services and defense and advanced technologies. It generates majority of revenue from communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers. It has presence in United States and Outside United States. The company generates majority of revenue from United States. Its products are Antennas, Terminals & radios, Modems, Semiconductors, Cybersecurity, Software & services, Home internet.

Share on Social Networks: